They also discovered that in the subgroup analysis by cancer type, HHLA2 overexpression correlated with poor OS in patients with clear cell renal cell carcinoma, gastric cancer, cholangiocarcinoma, lung cancer, and other cancer types, but not in patients with ovarian cancer [11]. This evidence concerns the gene HHLA2 and ovarian carcinoma.